IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
Go back to IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001| (NASDAQ: IMNN) | Delayed: 1.58 +0.02 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.56 | 52 Week High | $ | |||
| Open | $1.56 | 52 Week Low | $ | |||
| Day High | $1.58 | P/E | N/A | |||
| Day Low | $1.54 | EPS | $ | |||
| Volume | 34,012 | |||||
